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The term "muscular dystrophy" covers a small group of inherited diseases characterized by wasting of certain muscles without evidence of d!seas~in the nervous~ystem. The various types differ in the mode of inheritance, age of onset primary site of attack, severity and rate of pro: gression, A number of studies have been carried out on the composition and metabolism of muscle biopsy samples obtained from patients, in the hope of throwing light on the fundamental nature ofthe disease. Also, as would be expected, many analyses have been carried out on blood and urine in a search for abnormalities. This review of the main findings is necessarily brief.
The biochemical studies on muscle must be ass~ssed in the conte~~of the extensive morphological changes, familiar to pathologists, which are manifested in the diseased muscle. The atrophy and disappearance of individual fibres, together with the proliferation of connective tissue and, sometimes, of fat result in gross changes in the overall composition of the tissue. Other features, such as the presence of invading macrophages or abortive attempts at regeneration by the muscle tissue would be also expected to cause changes, e.g. new or increased enzyme activities. The fundamental biochemical altertions, i.e. those which may be presumed to result more or less directly from the genetic aberration are likely to be greatly outnumbered by such secondary changes.
Several workers have compared the activity of various enzymes in dystrophic muscle (for references, see Pennington, 1964; Heyck, Laudahn and Luders, 1963) . In most cases, the reference base used, e.g. "non-collagen nitrogen," has bee~chosen to correlate approximately with the weight of true muscle fibre in the tissue sample. There is a pronounced decrease in the activity of several glycolytic enzymes and correspondingly the overall rate of glycolysis in vitro is low. The activity of adenylate kinase, creatine kinase and AMP deaminase is also decreased whilst that of cytochrome oxidase and some of the Krebs cycle enzymes has been reported as u.nchanged. Several enzymes, including cathep-s~ns, glucose 6-phosphate dehydrogenase, isocitrate dehydrogenase and 5-nucleotidase, show increased activity. It has not been demostrated that any of these changes are unique to muscular dystrophy; many, indeed, have been shown to accompany atrophy resulting from other causes in human and animal muscle.
The pos~ibility that. isoenzyme patterns may be altered m dystrophic muscle has been investigated in the case of lactate dehydrogenase by several workers (e.g, Lauryssens, Lauryssens and Zondag, 1964) with generally consistent results. A marked change, notably a relative reduction in the main (cathodic) band is found and it has been pointed out that the altered pattern resembles that of normal foetal muscle. Again, this c~ange occurs also in other types of muscle disease or after nerve section (Schapira and I?reyfus, 1.964), but it is, nevertheless, of considerable interest that muscle degeneration is accompanied by a return to the foetal lactate dehydrogenase isoenzyme pattern. A somewhat similar phenomenon has been described in connection with myoglobin in muscular dystrophy. Who~on, Hudgins and Conners (1961) reported that 1D Duchenne-type dystrophy the visible spectrum of cardiac myoglobin (metmyoglobin) resembled that from foetal muscle rather than normal cardiac muscle. The same was true of skeletal muscle myoglobin in a case of facio-sc~pulohumeral muscular dystrophy. Myoshi, Saijo, Kuryu and Oshima (1963) claimed differences in the ultraviolet spectrum of metmyoglobin from normal adult muscle and muscle in Duchenne-type dystrophy. Recently, Perkoff (1964) has shown that the major myoglobin component ("myoglobin AU) of adult muscle is markedly decreased in childhood muscular dystrophy, as well as in foetal muscle.
The main protein of the myofibrils, myosin is decreased in the fibres (Vignos and Lefkowitz 1959) . It seems unlikely, however, that thp rimary defect is i~the contractile system, since muscle .weakness IS not apparent until a high proportion of the fibres show marked atrophic c.hanges. Few other studies on muscle composition have appeared. A decreased potassium and increase? sodium content has been reported several times (e.g. Horvath, Berg, Cummings and Shy, 1955) and Blahd, Cassen and Lederer (1964) have reported a decreased body potassium in both patients and relatives.
The classical disturbance in excretory pattern in muscle disease, not confined to muscular dystrophy, is a creatinuria together with a diminished excretion of creatinine: there is also a decreased creatine tolerance. The creatinuria is generally attributed to a lower uptake by the muscles of creatine (synthesized elsewhere in the body) presumed to result from the reduced amount of muscle. Since most of the urinary creatinine arises from creatine in the muscles, the smaller excretion of creatinine is also understandable. This assumption is supported by the evidence of Benedict, Kalinsky, Scarrone, Wertheim and Stetten (1955) that some of the urinary creatine formed from labelled glycine administered to muscular dystrophy patients was newly synthesized and had not entered skeletal muscle. Recently, however, Fitch and Sinton (1964) have shown that in muscular dystrophy there is an increased rate of disappearance of radioactivity from urinary creatinine, after the administration oflabelled creatine. They suggest, therefore, that there may be a specific defect in the ability of muscle to bind creatine in this disease. Whilst this seems the most likely explanation, it is also conceivable that their results may be explained by a higher rate of exchange of creatine between muscle and blood, due to a higher level of creatine in blood.
Claims (based largely on paper chromatography) that there is an increased excretion of certain amino acids in muscular dystrophy have occasionally been reported (see Berger, 1962) . There is, however, no consistent pattern such as would indicate a defect in the metabolism of any specific amino acid. Muscle wasting appears to be the most likely explanation for these findings. Kibrick, Hashiro, Walters and Milhorat (1964) have found a significantly decreased excretion of hydroxyproline; this may be related to the large increase in muscle collagen.
Minor alterations in the concentration of a number of blood constituents have been reported, including an increase in pyruvate, phosphate, calcium and protein-bound iodine, and a decrease in citrate, chloride and cholesterol. Several workers (e.g. Oppenheimer and Milhorat, 1961) have found an increase in a. 2 -globulin, which, however, occurs also in other myopathies; there is some indication that it is due to an increase in glycoprotein. Smith, Fischer and Etterldorf (1962) provided evidence that in muscular dystrophy an abnormally high proportion of serum magnesium is bound to protein or other high molecular weight compounds.
By far the most striking alteration in the blood plasma in muscular dystrophy, as in many other diseases, is an increase in the activity of a number of enzymes, undoubtedly due to leakage from the diseased fibres. These include the following, all of which are present in substantial amounts in muscle fibres: (they are listed roughly in descending order of the relative increase in blood level) creatine kinase, phosphoglucomutase, aldolase, lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase, glucose phosphate isomerase, triose phosphate isomerase and malate dehydrogenase.
The rise in serum enzyme level is the only commonly used biochemical test for the diagnosis of muscular dystrophy; aldolase, aspartate aminotransferase and, latterly, creatine kinase have been usually measured for this purpose. Creatine kinase is to be preferred, on account of both sensitivity and specificity. Its concentration in skeletal muscle is very high; heart and brain contain much less, whilst the other important tissues (including erythrocytes) contain very little. Extensive measurements of serum creatine kinase levels have been recorded by Pearce, Pennington and Walton (1964) and other workers. By far the highest levels (up to 400 times normal) occur in the early stages of Duchenne-type muscular dystrophy. Progressively smaller values are encountered as the disease progresses. Elevations are smaller or absent in adult types of dystrophy, whilst values are usually normal in neurogenic muscle disease. Occasional high values (up to about 100 times normal) have been found in polymyositis. In Duchenne dystrophy the very high levels may precede by years the obvious clinical signs; it is even possible that high levels may be present at birth in all cases. A particularly valuable application of serum creatine kinase estimations is in the detection of female carriers of Duchenne-type dystrophy, which is normally inherited by a sex-linked recessive mechanism. The females carrying the trait are generally clinically normal, although muscle biopsies have revealed histopathological changes. However, roughly two-thirds display elevated serum creatine kinase levels, commonly 2-3 times normal, but occasionally very much higher. It has thus been possible to identify many such cases amongst feminine relatives of muscular dystrophy patients. The importance of this is evident when it is realized that a son born to a carrier has a 50 per cent chance of developing muscular dystrophy.
Finally, it must be considered whether any of the known biochemical changes provide a clue to the underlying mechanism of any type of muscular dystrophy. The relatively non-specific histological alterations give no clear guide and the electron microscope has, so far, not shown any specific abnormality in ultrastructure. Although some of the more recent observations have still to be followed up, there seems to be no reason to suppose that any of the biochemical abnormalities so far discovered have primary significance. It has been considered by some that the leakage of enzymes from the fibres denotes a defect in the membrane which is apparently not present in neurogenic muscle atrophy and is therefore likely to be a fundamental one. However, the observation that enzyme retention by fibres is readily upset by metabolic or mechanical damage (Zierler, 1958) would appear to make this less likely, although much more research on the factors involved in the passage of proteins across the sarcolemma is obviously necessary. It is by no means certain, even, that the primary defect in muscular dystrophy lies in the muscle itself, although this is the simpler assumption; the possibility of a myotoxin being produced elsewhere in the body or of a defect in the production by the body of a compound essential for the maintenance of the fibres has not been excluded. It is hoped that evidence on this important question may eventually come out of tissue culture studies. but culture of adult muscle is notoriously difficult and so far consistent results have not been obtained.
An inborn error of metabolism is a genetically determined lack of an enzyme (or of an enzymelike carrier substance involved in transport into or out of cells). Since the first description of such conditions by Garrod (1908) about 400 different inborn errors of metabolism and related conditions have been reported; related conditions include the storage diseases such as the lipidoses, "molecular diseases" such as the haemoglobin-opathies and bisalbuminaemia, and pharmacogenetic conditions such as pseudocholinesterase deficiency. A considerable number of inborn errors of metabolism are associated with disorders of the central nervous system -mental retardation, psychosis or neurological abnormality. The list is a formidable one and includes errors of the intermediary metabolism of amino acids, carbohydrates, lipids, porphyrins, purines, ... Member of the External Scientific Staff of the Medical Research Council.
